News

News

  • 09 December 2016

    Acting on the potential of action potentials: will bioelectronic medicines be the next biologics?

    Read more
  • 01 August 2016

    GSK and Verily to establish Galvani Bioelectronics – a new company dedicated to the development of bioelectronic medicines

    Read more

Portfolio News

  • CVRx secures $113 Million in new financing. Equity offering to support heart failure trial was oversubscribed

    Read more

    09 August 2016

  • SetPoint's breakthrough first-in-human study shows vagus nerve stimulation significantly reduces rheumatoid arthritis symptoms, inhibits cytokine production

    Read more

    04 July 2016